Middleton L - Search Results

1

African-American race is associated with a poorer overall survival rate for breast cancer patients treated with mastectomy and doxorubicin-based chemotherapy.

Woodward WA, Huang EH, McNeese MD, Perkins GH, Tucker SL, Strom EA, Middleton L, Hahn K, Hortobagyi GN, Buchholz TA. Woodward WA, et al. Among authors: middleton l. Cancer. 2006 Dec 1;107(11):2662-8. doi: 10.1002/cncr.22281. Cancer. 2006. PMID: 17061247 Free article.

2

Multicentric mammary carcinoma: evidence of monoclonal proliferation.

Middleton LP, Vlastos G, Mirza NQ, Eva S, Sahin AA. Middleton LP, et al. Cancer. 2002 Apr 1;94(7):1910-6. doi: 10.1002/cncr.10452. Cancer. 2002. PMID: 11932891 Free article.

3

Assessment of histologic features and expression of biomarkers in predicting pathologic response to anthracycline-based neoadjuvant chemotherapy in patients with breast carcinoma.

Wang J, Buchholz TA, Middleton LP, Allred DC, Tucker SL, Kuerer HM, Esteva FJ, Hortobagyi GN, Sahin AA. Wang J, et al. Among authors: middleton lp. Cancer. 2002 Jun 15;94(12):3107-14. doi: 10.1002/cncr.10585. Cancer. 2002. PMID: 12115341 Free article.

4

Histopathology of breast cancer among African-American women.

Middleton LP, Chen V, Perkins GH, Pinn V, Page D. Middleton LP, et al. Cancer. 2003 Jan 1;97(1 Suppl):253-7. doi: 10.1002/cncr.11021. Cancer. 2003. PMID: 12491489 Free article. Review.

5

Breast cancer in men.

Perkins GH, Middleton LP. Perkins GH, et al. BMJ. 2003 Aug 2;327(7409):239-40. doi: 10.1136/bmj.327.7409.239. BMJ. 2003. PMID: 12896911 Free PMC article. No abstract available.

6

Breast carcinoma in pregnant women: assessment of clinicopathologic and immunohistochemical features.

Middleton LP, Amin M, Gwyn K, Theriault R, Sahin A. Middleton LP, et al. Cancer. 2003 Sep 1;98(5):1055-60. doi: 10.1002/cncr.11614. Cancer. 2003. PMID: 12942575 Free article.

7

Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields.

Shahar KH, Hunt KK, Thames HD, Ross MI, Perkins GH, Kuerer HM, Strom EA, McNeese MD, Meric F, Schechter NR, Sahin AA, Middleton LP, Buchholz TA. Shahar KH, et al. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1074-9. doi: 10.1016/j.ijrobp.2004.01.003. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234041

8

HER-2/neu and p53 overexpression as biomarkers of breast carcinoma in women age 30 years and younger.

Maru D, Middleton LP, Wang S, Valero V, Sahin A. Maru D, et al. Cancer. 2005 Mar 1;103(5):900-5. doi: 10.1002/cncr.20850. Cancer. 2005. PMID: 15643600 Free article.

9

Clinical outcome of patients with lymph node-negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistry.

Chagpar A, Middleton LP, Sahin AA, Meric-Bernstam F, Kuerer HM, Feig BW, Ross MI, Ames FC, Singletary SE, Buchholz TA, Valero V, Hunt KK. Chagpar A, et al. Cancer. 2005 Apr 15;103(8):1581-6. doi: 10.1002/cncr.20934. Cancer. 2005. PMID: 15747375 Free article. Review.

10

Adjuvant systemic therapy for male breast carcinoma.

Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, Hortobagyi GN. Giordano SH, et al. Cancer. 2005 Dec 1;104(11):2359-64. doi: 10.1002/cncr.21526. Cancer. 2005. PMID: 16270318 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

607 results

Search Page

Filters